OMICS Group recently launched a new open-access journal called Diagnostic Pathology: Open Access. The title closely matches that of the BioMed Central (BMC) journal Diagnostic Pathology. It also matches the scope of The Diagnostic Pathology Journal, a new open-access journal launched by the former editor-in-chief of the BMC journal.
The Journal of Chest is a new medical journal published by the OMICS-Group-owned Insight Medical Publishing (ImedPub). The journal is competing in a sleazy way with the legitimate and respected medical journal CHEST, published since 1935 by the American College of Chest Physicians.
Hyderabad, India-based OMICS Group has found a new and likely lucrative revenue source — charging authors to withdraw their submissions to the publisher’s many journals.
The International Journal of Cardiovascular Research is a subscription journal published by the OMICS Group imprint called SciTechnol. This is a hybrid journal, meaning it’s a subscription journal with an option for authors to pay a fee and have the article made open access.
OMICS Group continues to launch and publish scholarly journals whose titles closely match those of established and respected journals, including journals published by scholarly societies. OMICS Group’s goal is to trick researchers into thinking the OMICS journals are actually the legitimate journals, so they can get the author fees from the authors.
Massachusetts-based Aries Systems licenses a product called Editorial Manager to scholarly publishers. This is an online product that helps manage article submission and peer review for journals. Regrettably, one of Aries Systems’ clients is a notorious publisher that victimizes scholarly authors.